Beacon Pointe Advisors, LLC Viatris Inc Transaction History
Beacon Pointe Advisors, LLC
- $8.35 Billion
- Q2 2024
A detailed history of Beacon Pointe Advisors, LLC transactions in Viatris Inc stock. As of the latest transaction made, Beacon Pointe Advisors, LLC holds 15,125 shares of VTRS stock, worth $174,693. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,125
Previous 26,712
43.38%
Holding current value
$174,693
Previous $318,000
49.69%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding VTRS
# of Institutions
1,100Shares Held
969MCall Options Held
2.63MPut Options Held
2.15M-
Vanguard Group Inc Valley Forge, PA140MShares$1.62 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$1.07 Billion0.02% of portfolio
-
State Street Corp Boston, MA62.1MShares$717 Million0.03% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az57.5MShares$665 Million3.55% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD56.8MShares$656 Million0.07% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $14B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...